Nigeria's goal of eliminating malaria is now being threatened after a new study shows disturbing evidence that malaria is rapidly becoming resistant to Artemisinin-based Combination Therapy (ACT) drugs critical for the treatment of the disease in the country.
Experts have raised concern that this
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
